Literature DB >> 35245676

Dopaminergic modulation of primary motor cortex: From cellular and synaptic mechanisms underlying motor learning to cognitive symptoms in Parkinson's disease.

Jérémy Cousineau1, Valentin Plateau1, Jérôme Baufreton1, Morgane Le Bon-Jégo2.   

Abstract

The primary motor cortex (M1) is crucial for movement execution, especially dexterous ones, but also for cognitive functions like motor learning. The acquisition of motor skills to execute dexterous movements requires dopamine-dependent and -independent plasticity mechanisms within M1. In addition to the basal ganglia, M1 is disturbed in Parkinson's disease (PD). However, little is known about how the lack of dopamine (DA), characteristic of PD, directly or indirectly impacts M1 circuitry. Here we review data from studies of PD patients and the substantial research in non-human primate and rodent models of DA depletion. These models enable us to understand the importance of DA in M1 physiology at the behavioral, network, cellular, and synaptic levels. We first summarize M1 functions and neuronal populations in mammals. We then look at the origin of M1 DA and the cellular location of its receptors and explore the impact of DA loss on M1 physiology, motor, and executive functions. Finally, we discuss how PD treatments impact M1 functions.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Intrinsic and synaptic plasticity; M1 forelimb area; Motor learning; Parkinson’s disease; Primary motor cortex

Mesh:

Substances:

Year:  2022        PMID: 35245676     DOI: 10.1016/j.nbd.2022.105674

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  1 in total

1.  Adaptive structural changes in the motor cortex and white matter in Parkinson's disease.

Authors:  YuHong Fu; Liche Zhou; Hongyun Li; Jen-Hsiang T Hsiao; Binyin Li; Onur Tanglay; Andrew D Auwyang; Elinor Wang; Jieyao Feng; Woojin S Kim; Jun Liu; Glenda M Halliday
Journal:  Acta Neuropathol       Date:  2022-09-02       Impact factor: 15.887

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.